about
Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function.Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus.Progression to type 2 diabetes in women with former gestational diabetes: time trajectories of metabolic parameters.Effects of insulin therapy on myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus.Glucose absorption in gestational diabetes mellitus during an oral glucose tolerance testHepatic rather than cardiac steatosis relates to glucose intolerance in women with prior gestational diabetesHidden metabolic disturbances in women with normal glucose tolerance five years after gestational diabetes.Multiparametric MR Imaging Depicts Glycosaminoglycan Change in the Achilles Tendon during Ciprofloxacin Administration in Healthy Men: Initial Observation.Incretin Effect in Women with Former Gestational Diabetes within a Short Period after Delivery.Pericardial- Rather than Intramyocardial Fat Is Independently Associated with Left Ventricular Systolic Heart Function in Metabolically Healthy Humans.CTX (crosslaps) rather than osteopontin is associated with disturbed glucose metabolism in gestational diabetes.A Case of "Late-Onset" Idiopathic Infantile Hypercalcemia Secondary to Mutations in the CYP24A1 Gene.Intracellular lipid accumulation and shift during diabetes progression.Potential of a Sports Club-Based Exercise Program for Improving Physical Activity in Type 2 Diabetes Mellitus.The Cross-Link between Adipokines, Insulin Resistance and Obesity in Offspring of Diabetic Pregnancies.Clinical presentation in insulinoma predicts histopathological tumour characteristics.Free fatty acid availability is closely related to myocardial lipid storage and cardiac function in hypoglycemia counterregulation.Cardiometabolic phenotyping of patients with familial hypocalcuric hypercalcemia.Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters.Recruitment of patients with type 2 diabetes for target group specific exercise programs at an Outpatient Department of a Medical University: A factor analysis.HORMONE SUBSTITUTION AFTER GASTRIC BYPASS SURGERY IN PATIENTS WITH HYPOPITUITARISM SECONDARY TO CRANIOPHARYNGIOMA.Fasting and postprandial liver glycogen content in patients with type 1 diabetes mellitus after successful pancreas-kidney transplantation with systemic venous insulin delivery.Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes.Non-esterified fatty acid dynamics during oral glucose tolerance test in women with former gestational diabetes.Tigecycline as last resort in severe refractory Clostridium difficile infection: a case reportNo Evidence of Ectopic Lipid Accumulation in the Pathophysiology of the Acromegalic CardiomyopathyThe impact of recurrent gestational diabetes on maternal metabolic and cardiovascular risk factorsInsulin resistance is not associated with myocardial steatosis in womenShape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance?
P50
Q30841455-006EBAD8-8CDA-4599-BF05-F0C6FBEDE25AQ33556735-8B52E1A0-DDCD-4C86-9544-1333514C740AQ34491423-F7C1D7D8-9A6A-4EA8-9E0F-F466B19B7403Q34506453-ECBC0D36-09F6-463C-89C9-144D1B80CCF8Q35060215-80334FC3-DEF2-4236-98C3-CB6185893A6EQ35118617-3B4A92AF-E8E6-49DE-B880-5DB9E61FEDD4Q35271525-FACB14A2-60E1-427B-B05A-B5D197DC408AQ35637360-B270D09D-734D-4799-8C73-772B3B5E814EQ35936659-1DFBB766-4FA8-47A3-A8D6-BBCDB7C2EA32Q35953956-3A879365-066C-41DE-8596-83A08528A5C8Q36109661-0A8B89CB-253E-420C-A688-E73B831F6037Q38187232-E718B3A3-59A5-4AC2-BA92-407A8270E6ADQ38232287-A6931D05-C501-4C91-AEE5-FD17320A255BQ38392335-B0398187-DA3E-46B2-BFE4-5840FDD7CD0BQ38818709-E8B10FEF-B49C-473D-8411-F7D25C748FC0Q41148371-28EDB347-5A7B-4592-85F8-A69432FC24E2Q41451542-CE6CF732-B4AA-4E4E-8121-565D6386CAF0Q42460960-848CEADD-81FE-43C6-A54E-209E28029379Q44800632-3ECE8985-1580-4B06-B33A-875506086F17Q48138739-D907023A-ACA9-4577-A859-0ABFFA4E22D5Q48961195-BAFCE1D5-CC76-47D5-968A-2DB2862A82CDQ51346542-0196E412-DFFB-48A4-BE81-F14DF4D26ACCQ51355578-2481CE0E-93D9-496C-A7E3-0F4E01BFD0E8Q51366942-F2BB19D9-86FE-40B8-B396-11F099DF2814Q59298050-8E641D58-EF90-4615-A03E-BE43E2C10840Q62003327-33D18221-BECB-4ACA-9403-65B6F4BE36DCQ62003343-C4D637B1-B680-4926-8E0C-7D87190F6A03Q62003364-D6F6D3C2-3DD4-4FFD-A748-353D7A99693EQ62003370-95CC1902-0825-453C-AEFC-5B082B7B1E57
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Yvonne Winhofer
@ast
Yvonne Winhofer
@en
Yvonne Winhofer
@es
Yvonne Winhofer
@sl
type
label
Yvonne Winhofer
@ast
Yvonne Winhofer
@en
Yvonne Winhofer
@es
Yvonne Winhofer
@sl
prefLabel
Yvonne Winhofer
@ast
Yvonne Winhofer
@en
Yvonne Winhofer
@es
Yvonne Winhofer
@sl
P106
P21
P214
73146825552407632520
P31
P496
0000-0002-0555-9044
P735
P7859
viaf-73146825552407632520